← Latest Filings
S

Staab Thomas R II

Chief Financial Officer

Open-market buys
1
$11K total
Open-market sells
0
$0 total
Tracking since
Sep 2026
Open-market buy — $11K
TENAX THERAPEUTICS, INC. · Sep 11, 2026
Open-market trades from the last two years.
450,000 Stock Option (right to buy) in TENX
Held directly · as of 2026-09-11
174,609 Common Stock in LNSR
Held directly · as of 2026-05-06
TENAX THERAPEUTICS, INC.
CIK 0000034956
LENSAR, Inc.
CIK 0001320350